Equity Overview
Price & Market Data
Price: $11.29
Daily Change: -$0.12 / 1.06%
Daily Range: $10.96 - $11.49
Market Cap: $431,495,136
Daily Volume: 166,836
Performance Metrics
1 Week: 4.54%
1 Month: -0.09%
3 Months: 28.00%
6 Months: 112.6%
1 Year: -13.62%
YTD: 9.82%
Company Details
Employees: 183
Sector: Health technology
Industry: Biotechnology
Country:
Details
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV™)-therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA- and protein-based programmes for the potential treatment of neuromuscular and ocular diseases, among others. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.